We are really keen to engage with the InSiGHT membership and find out how we can improve! Please complete this survey docs.google.com/forms/d/e/1FAI… Sonia Kupfer Francesc Balaguer Daniel Buchanan Kevin Monahan Laura Valle Toni Seppälä

Last chance to tell us your views!

Thanks to all who responded to our survey, we will be in touch if you have expressed an interest in getting more involved!

... and excited to see Solve-RD legacy continue & expand within ERDERA with more European Reference Networks (ERNs) involved, and also more (also under-represented) countries on board! ERDERA: cordis.europa.eu/project/id/101… ; @ERN_RND 🧠 ERN-ITHACA NicolineHoogerbrugge ern euro_nmd

🎉 Happy to share our newly published Review: "Genetics, genomics and clinical features of adenomatous polyposis" Joo JE, Viana-Errasti J, et al. A collaboration between Daniel Buchanan and Laura Valle Now available in Familial Cancer: link.springer.com/article/10.100…

🧬 On #WorldDNADay, let’s remember: understanding DNA isn’t just science—it’s lifesaving. #HereditaryGICancer often goes undetected. #Healthcare professionals play a critical role in identifying at-risk patients through family history & #genetictesting. Early detection starts

One hundred years of the St Mark’s hospital polyposis registry London North West University Healthcare LynchSyndrome_Polyposis@StMarks St Mark's Hospital Foundation link.springer.com/article/10.100…

🎙️ Join us for #PrevenTalk3 – 6 May, 11:00 CET (Online & Free!) Theme: Advancing Care for Rare Tumour Risk Syndromes (RTRS) through Policy, Economics & EU Collaboration. 👤 Speakers: Dr Romana Jerković & Dr Ignacio Blanco Guillermo 📌 Register: ec.europa.eu/eusurvey/runne…

What factors affect access to genetic tests? This study from Australia draws attention to the geographical and socioeconomic challenges and provides a foundation for further studies on genomic testing accessibility and equity. nature.com/articles/s4143…

🚨 Today is your LAST CHANCE to register for #PrevenTalk3! 🚨 📅 Tomorrow, 6 May 2025, at 11:00 CET, with experts: 🔹Dr. Romana Jerković 🔹 Dr. Ignacio Blanco Guillermo 🔹 Dr. Jana Votápková 🔹 Prof. Stefan Aretz Hosted by Alexis Strader, EHMA Register: ec.europa.eu/eusurvey/runne…

On behalf of InSiGHT, we are delighted to welcome you to the #InSiGHT2026 meeting in Singapore, taking place from 4 – 7 March 2026 #LynchSyndrome #Polyposis InSiGHT Laura Valle Francesc Balaguer Daniel Buchanan Kevin Monahan insight2026.org/welcome-messag…

1/Welcome to #CGAIGCJS Tweetorial on “Cancer and Overgrowth Manifestations of PTEN Hamartoma Tumor Syndrome: Management Recommendations from the International PHTS Consensus Guidelines Working Group” by #CGAIGC Communications Committee member Monika Laszkowska, MD, MS ➡️Full article in

Submit your abstracts now! #Insight2026 insight2026.org Deadline 7th September #LynchSyndrome #Polyposis #EOCRC Laura Valle Kevin Monahan Daniel Buchanan Francesc Balaguer NicolineHoogerbrugge CGA-IGC European Hereditary Tumour Group

Staying one step ahead. Identifying patients with #PHTS before or at first primary cancer diagnosis can enable #early #detection of second primary #cancer. bit.ly/4eUSVfg NicolineHoogerbrugge

Great to see York Posor’s work on PI3K-C2alpha published: shorturl.at/d8Y5C, concluding 25 years of research in CellSig_Lab, dedicated to elucidating the roles of @PI3K family members by gene targeting. Many thanks to Sarah conduit & Biotechnology and Biological Sciences Research EMBO Marie Skłodowska-Curie Actions Science and Innovation at Cancer Research UK

Jawel een steltkluten familie gezien! Prachtig hè!! Zo vlak bij de lepelaars.

Don't forget to submit your #Insight2026 abstracts before 7th September #LynchSyndrome #Polyposis

🌏 InSiGHT Biennial Meeting is coming to Singapore! 📅 4–7 March 2026 📝 Abstracts due: 20 Sept 2025 🎟️ Early Bird ends: 10 Jan 2026 Join global experts in hereditary GI cancer research. #InSiGHT2026 #MedicalResearch #Singapore

Please submit your abstracts now! The closing date is approaching for #Insight2026 #LynchSyndrome #Polyposis

Proudly introducing Professor Sir John Burn (Sir John Burn) as our invited speaker for #CGAIGC25! Sir John Burn is Newcastle University's Professor of Clinical Genetics leading the Cancer Prevention Programme (CaPP) and an honorary NHS consultant in the regional Genetics Service, which he